2月28日早盘,港股关键指数调整,科技股普调,医药股走势分化,恒生医药ETF(159892)重仓股百济神州一度大涨超7%,微创医疗、微创机器人等跌幅靠前。据百济神州公告,其2024年第四季度全球总收入达11亿美元,同比增长78%,全年全球总收入达38亿美元,同比增长55%;GAAP经营亏损持续收窄,实现全年非GAAP经营利润为正。恒生医药ETF跟踪恒生生物科技指数,指数成分股中,药明生物权重...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.